GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Selling and Marketing Expense

Progen Co (XKRX:296160) Selling and Marketing Expense : ₩ Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Progen Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Progen Co's Selling and Marketing Expense for the six months ended in Dec. 2024 was ₩916.2 Mil. Progen Co does not have enough years/quarters to calculate the Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024.

Progen Co Selling and Marketing Expense Historical Data

The historical data trend for Progen Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progen Co Selling and Marketing Expense Chart

Progen Co Annual Data
Trend Dec23 Dec24
Selling and Marketing Expense
2,587.06 916.16

Progen Co Semi-Annual Data
Dec23 Dec24
Selling and Marketing Expense 2,587.06 916.16

Progen Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Progen Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Progen Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Progen Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Selling and Marketing Expense
Comparable Companies
XKRX:222110 XKRX:299660 XKRX:348080 XKRX:261780 XKRX:038070 XKRX:308080 XKRX:168330 XKRX:383930 XKRX:046210 XKRX:456570 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
172 Magokjungang-ro, 7th Floor, Bio Innovation Park, Gangseo-gu, Seoul, KOR
Website
http://www.progen.co.kr
Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.

Progen Co Headlines

No Headlines